Phreesia Shares Touch All-time Lows After Revenue Guidance Cut

Dow Jones
Mar 31
 

By Stephen Nakrosis

 

Shares of Phreesia were trading at all-time lows in the after-hours market Monday, after the company cut its fiscal year 2027 revenue guidance.

After the closing bell, Phreesia said it was cutting guidance for FY27 revenue to $510 million to $520 million, from the previous range of $545 million to $559 million.

"As we discussed on our last earnings call in December 2025, we are experiencing shorter visibility into spending commitments by certain pharmaceutical manufacturers," Phreesia said.

Shares were trading at $9 after hours, down $21% from the day's regular session closing price of $11.41. On March 16, the stock touched a 52-week low of $10.75.

For the fourth quarter, Phreesia reported earnings per share of 2 cents on revenue of $127.1 million. In the year-ago period, the company had a loss per share of 11 cents on revenue of $109.7 million.

Phreesia provides patient check-in solutions for medical practices.

 

Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

 

(END) Dow Jones Newswires

March 30, 2026 17:13 ET (21:13 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10